These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 27898323)

  • 1. Peripheral blood nerve growth factor levels in major psychiatric disorders.
    Rao S; Martínez-Cengotitabengoa M; Yao Y; Guo Z; Xu Q; Li S; Zhou X; Zhang F
    J Psychiatr Res; 2017 Mar; 86():39-45. PubMed ID: 27898323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia.
    Qin XY; Wu HT; Cao C; Loh YP; Cheng Y
    Mol Psychiatry; 2017 Sep; 22(9):1306-1312. PubMed ID: 28070123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of nerve growth factor (NGF) in patients with major depression disorder and suicide risk.
    Wiener CD; de Mello Ferreira S; Pedrotti Moreira F; Bittencourt G; de Oliveira JF; Lopez Molina M; Jansen K; de Mattos Souza LD; Rizzato Lara D; Portela LV; da Silva RA; Oses JP
    J Affect Disord; 2015 Sep; 184():245-8. PubMed ID: 26118751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significantly lower nerve growth factor levels in patients with major depressive disorder than in healthy subjects: a meta-analysis and systematic review.
    Chen YW; Lin PY; Tu KY; Cheng YS; Wu CK; Tseng PT
    Neuropsychiatr Dis Treat; 2015; 11():925-33. PubMed ID: 25897228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor in major depressive disorder, schizophrenia, and bipolar disorder: A network meta-analysis.
    Pu J; Liu Y; Gui S; Tian L; Xu S; Song X; Zhong X; Chen Y; Chen X; Yu Y; Liu L; Zhang H; Wang H; Zhou C; Zhao L; Xie P
    Psychiatry Res; 2020 Oct; 292():113319. PubMed ID: 32717712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients.
    Kale A; Joshi S; Pillai A; Naphade N; Raju M; Nasrallah H; Mahadik SP
    Schizophr Res; 2009 Dec; 115(2-3):209-14. PubMed ID: 19713082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced NGF serum levels and abnormal P300 event-related potential in first episode schizophrenia.
    Xiong P; Zeng Y; Zhu Z; Tan D; Xu F; Lu J; Wan J; Ma M
    Schizophr Res; 2010 Jun; 119(1-3):34-9. PubMed ID: 20303241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of NGF and IL-2 serum level in assisting the diagnosis in first episode schizophrenia.
    Xiong P; Zeng Y; Wan J; Xiaohan DH; Tan D; Lu J; Xu F; Li HY; Zhu Z; Ma M
    Psychiatry Res; 2011 Aug; 189(1):72-6. PubMed ID: 21277636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH; Kim YK
    Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher serum nerve growth factor levels are associated with major depressive disorder pathophysiology: a case-control study.
    Salsabil L; Shahriar M; Islam SMA; Bhuiyan MA; Qusar MS; Islam MR
    J Int Med Res; 2023 Apr; 51(4):3000605231166222. PubMed ID: 37038918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Clinical Characteristics to Identify Which Patients With Major Depressive Disorder Have a Higher Genetic Load for Three Psychiatric Disorders.
    Verduijn J; Milaneschi Y; Peyrot WJ; Hottenga JJ; Abdellaoui A; de Geus EJC; Smit JH; Breen G; Lewis CM; Boomsma DI; Beekman ATF; Penninx BWJH
    Biol Psychiatry; 2017 Feb; 81(4):316-324. PubMed ID: 27576130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced serum nerve growth factor in patients with late-life depression.
    Diniz BS; Teixeira AL; Machado-Vieira R; Talib LL; Gattaz WF; Forlenza OV
    Am J Geriatr Psychiatry; 2013 May; 21(5):493-6. PubMed ID: 23570892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome.
    Parikh V; Evans DR; Khan MM; Mahadik SP
    Schizophr Res; 2003 Apr; 60(2-3):117-23. PubMed ID: 12591576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral levels of BDNF and NGF in primary headaches.
    Blandini F; Rinaldi L; Tassorelli C; Sances G; Motta M; Samuele A; Fancellu R; Nappi G; Leon A
    Cephalalgia; 2006 Feb; 26(2):136-42. PubMed ID: 16426267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TREM-1 and DAP12 expression in monocytes of patients with severe psychiatric disorders. EGR3, ATF3 and PU.1 as important transcription factors.
    Weigelt K; Carvalho LA; Drexhage RC; Wijkhuijs A; de Wit H; van Beveren NJ; Birkenhäger TK; Bergink V; Drexhage HA
    Brain Behav Immun; 2011 Aug; 25(6):1162-9. PubMed ID: 21421043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultradian variation of nerve growth factor plasma levels in healthy and schizophrenic subjects.
    Bersani G; Iannitelli A; Massoni E; Garavini A; Grilli A; Di Giannantonio M; Conti CM; Pancheri P
    Int J Immunopathol Pharmacol; 2004; 17(3):367-72. PubMed ID: 15461870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring Serum Levels of Brain Derived Neurotrophic Factor and Nerve Growth Factor Across Glaucoma Stages.
    Oddone F; Roberti G; Micera A; Busanello A; Bonini S; Quaranta L; Agnifili L; Manni G
    PLoS One; 2017; 12(1):e0168565. PubMed ID: 28068360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress, anxiety and schizophrenia and neurotrophic factors: the pioneer studies with nerve growth factor.
    Gioiosa L; Iannitelli A; Aloe L
    Riv Psichiatr; 2009; 44(2):88-94. PubMed ID: 20066809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurements of C-reactive protein (CRP) and nerve-growth-factor (NGF) concentrations in serum and urine samples of dogs with neurologic disorders.
    Kordass U; Carlson R; Stein VM; Tipold A
    BMC Vet Res; 2016 Jan; 12():7. PubMed ID: 26746899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polygenic associations of neurodevelopmental genes in suicide attempt.
    Sokolowski M; Wasserman J; Wasserman D
    Mol Psychiatry; 2016 Oct; 21(10):1381-90. PubMed ID: 26666204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.